Tetrahydrocannabinolic Acid (THC-a) Research Dashboard
Double-blind human trials
Clinical human trials
What am I missing as a non-subscriber?
To see a full dashboard with study details and filtering, go to our DEMO page.
As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.
CannaKeys has 41 studies associated with Tetrahydrocannabinolic Acid (THC-a).
Here is a small sampling of Tetrahydrocannabinolic Acid (THC-a) studies by title:
- Evaluation of the Possible Anticonvulsant Effect of Δ 9-Tetrahydrocannabinolic Acid in Murine Seizure Models
- Modulation of Recombinant Human T-Type Calcium Channels by Δ 9-Tetrahydrocannabinolic Acid In Vitro
- Fighting the storm: could novel anti-TNFα and anti-IL-6 C. sativa cultivars tame cytokine storm in COVID-19?
- Δ9-Tetrahydrocannabinolic Acid markedly alleviates liver fibrosis and inflammation in mice
- Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings
Components of the Tetrahydrocannabinolic Acid (THC-a) Research Dashboard
- Top medical conditions associated with Tetrahydrocannabinolic Acid (THC-a)
- Proven effects in clinical trials for Tetrahydrocannabinolic Acid (THC-a)
- Receptors associated with Tetrahydrocannabinolic Acid (THC-a)
- Individual study details for Tetrahydrocannabinolic Acid (THC-a)
Ready to become a subscriber? Go to our PRICING page.
Members can filter by the following criteria:
- Study Type
- Organ Systems
- Study Result
- Year of Publication
Overview - Tetrahydrocannabinolic Acid (THC-a)
Description of Tetrahydrocannabinolic Acid (THC-a)
The plant-based (phytocannabinoid) Delta-9-THC-Acid was discovered in 1969. It is the essential precursor to THC the primary psychoactive phytocannabinoid.
Delta 9-Tetrahydrocannabinolic Acid
Tetrahydrocannabinolic Acid (THC-a) Properties and Effects
Anti-emetic, Hypothermic, Antineoplastic, Anti-inflammatory, Neuroprotective
Tetrahydrocannabinolic Acid (THC-a) Receptor Binding
CB1 contradictory results indicating possible tissue specific activation (i.e. positive agonism at peripheral CB1 but not central CB1 activation). CB2 contradictory results
Disclaimers: Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for diagnosing a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider.
Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.